Genetic profile of lung cancer can predict disease’s next move
A comprehensive analysis by British researchers of the way lung cancer evolves over time gives medical scientists a new means of predicting how individual patients’ tumours will develop and deciding how best to treat them.
Cancer Research UK released the results on Wednesday of a £14mn study called TracerX involving 800 patients over a nine-year period. Lung cancer is the world’s most deadly cancer, killing about 35,000 people a year in the UK.
This story originally appeared on: Financial Times - Author:Clive Cookson
